The Northern Babies Longitudinal Study

May 15, 2019 updated by: University of Tromso

The Northern Babies Longitudinal Study: Predicting Postpartum Depression and Improving Parent-infant Interaction With The Newborn Behavioral Observation

Postpartum depression (PPD) is a prevalent disorder. Studying the factors related to PPD will help to identify families at risk and provide preventive interventions. This can in turn improve the developmental trajectories for the children. Several previous studies have investigated risk factors for PPD. However, few studies have focused on cognitive vulnerability factors. The first aim of the present study is to explore a range of protective and risk factors, including cognitive factors, for PPD, parent-infant interactions and child development. The second aim of the study is to evaluate the effectiveness of The Newborn Behavioral Observation (NBO) as a universal preventive intervention delivered in routine practice. The NBO is a brief relationship-enhancing intervention that may reduce depressive symptomatology in mothers.

Study Overview

Detailed Description

Aims

The present study has three broad aims:

  1. Examine key pre- and postnatal predictors related to parental functioning: a) parental depression, anxiety, and stress, b) parental reflective functioning in relation to the infant, and c) parent-infant attachment style.
  2. Examine key pre- and postnatal predictors related to interaction and developmental problems in the child: a) difficulties in parent-infant interaction in the first 4 months post-delivery, and b) infant's cognitive, communicative and motor development, signs of sustained withdrawal behaviour, and heart-rate variability at 6 months post-delivery.
  3. Evaluate the effectiveness of the NBO as a universal preventive intervention delivered in routine practice as compared to standard care, on:

    • Parental outcomes (depressive symptoms, parenting stress, reflective functioning, attachment to the infant),
    • Relational outcomes (emotional availability in parent-child interaction), and
    • Infant outcomes (cognitive, communicative and motor development at 6 months post-delivery, heart-rate variability).

Predictor variables include some well-known vulnerability factors for developing PPD (e.g., depression symptoms in pregnancy, adult attachment style, relationship satisfaction and life stress), but the main focus in the observational part of the research project is on cognitive vulnerability factors such as early maladaptive schemas, repetitive negative thinking, rumination, implicit attitudes and cognitive processing of emotionally valenced infant facial information.

Study design This is a longitudinal observational study with an intervention. The observational part of the study will use a prospective cohort design. The effect of the intervention will be evaluated using a non-randomized cluster controlled design, since neither cluster nor individual randomization is feasible in this routine practice setting. An intervention group receiving NBO (families belonging to two well-baby clinics in Tromsø municipality) will be compared with a control group (families at the remaining four well-baby clinics in Tromsø) receiving care as usual.

Recruitment All pregnant women and expecting fathers who speak Norwegian are eligible for inclusion in the study. Between autumn 2015 and autumn 2018 approximately 200 families will be recruited by midwifes and by general practitioners (GPs) in the municipality of Tromsø, which is the 9th largest municipality in Norway (~73000 inhabitants; 78). There are approximately 1000 births a year in Tromsø municipality. Based on the experiences from a comparable study, "Little in Norway" (79), the recruitment of 200 families within the project period is considered feasible.

The participants will be recruited in (approximately) week 16 of gestation. At recruitment, women will be given written information about the study and a flyer with an inquiry to be contacted by the research team. If the child's father is not present, the mother is encouraged to inform him about the study. The health worker informs the research team who contacts the women to plan a meeting with them and their partners, preferable between week 16 and 22 of gestation. In this meeting, the prospective parents are given detailed information about the study and are invited to sign an informed consent to participate. In addition, at 4 months post-delivery the parents will be asked to sign an informed consent to obtain birth related information from the birth record.

Power calculations/statistical analysis The sample size is calculated on the basis of differences between intervention group and standard care group on the Edinburgh Postnatal Depression Scale (EPDS) maternal score, the Parenting Stress Index (PSI-PD), the Parental Reflective Functioning Scale (PRFQ) and the Maternal Postnatal Attachment Scale (MPAS) 6 weeks post-delivery. Based on the pilotstudy by Nugent et al. (69) and some regression to the mean, we expect a small to medium effect size (f2 = .07). A MANOVA with the four aforementioned outcome variables can detect a difference between the groups with a power of .80 given a group sizes of N = 176. With an estimated dropout of 10 %, a group size of 200 will be recruited. The estimation is based on an α-level of .05.

Procedure For the observational part of the study, assessments will be performed at six time points (see Table 1): During gestational week 16 - 22 (Step 1), 24 - 30 (Step 2) and 31 (Step 3), and at 6 weeks (Step 4), 4 months (Step 5) and 6 months (Step 6) post-delivery. For the intervention study, pre-intervention measures will be collected at Step 3, post-intervention measures at Step 4 and follow-up measures at Step 5 and 6. Since the families will receive the first NBO already two-days post-delivery, no pre-test assessment can be obtained for the interaction and infant measures. Hence, analyses of intervention effects will be based on differences between groups at 4 and 6 months post-delivery controlling for relevant covariates. The data is collected using online questionnaires, computerized cognitive tests, video-filmed observations of mother-infant interactions, and a standardised test of the child's cognitive, communicative and motor development (Bayley Scales of Infant and Toddler Development; 80).

Study Type

Interventional

Enrollment (Actual)

350

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tromso, Norway
        • UiT The Arctic University of Norway

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Pregnant woman and expecting fathers
  • Speak Norwegian

Exclusion Criteria:

  • Do not speak Norwegian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NBO plus routine care
The Newborn Behavioral Observation

The Newborn Behavioral Observation (NBO) is a flexible parental guidance methodology which takes between 20 and 40 minutes to administer. It consists of 18 neurobehavioral observations which give a profile of the infant´s behavioral repertoire along the dimensions: attentional-interactional, autonomic, motor and state organization.

The intervention group will receive 3 NBO consultations: 1) Routine care plus the NBO at the hospital within two days post-delivery; 2) Routine home visit plus the NBO by a public health nurse when the infant is 7-10 days old; and 3) NBO at the well-baby clinic when the infant is about 4 weeks old.

Other Names:
  • NBO
The control group will receive routine care. Between 7 and 10 days after birth a public health nurse routinely visits the family at home. Six weeks after birth, the mother and the infant visit the well-baby clinic
Other: Routine care
The control group will receive routine care. Between 7 and 10 days after birth a public health nurse routinely visits the family at home. Six weeks after birth, the mother and the infant visit the well-baby clinic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Levels of postpartum depression
Time Frame: Six weeks postpartum
Mothers and fathers self-reported levels of postpartum depression measured with the Edinburgh Postnatal Depression Scale.
Six weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Levels of postpartum depression
Time Frame: Four months postpartum
Mothers and fathers self-reported levels of postpartum depression measured with the Edinburgh Postnatal Depression Scale.
Four months postpartum
Levels of postpartum depression
Time Frame: Six months postpartum
Mothers and fathers self-reported levels of postpartum depression measured with the Edinburgh Postnatal Depression Scale.
Six months postpartum
Parental reflective functioning
Time Frame: Six weeks postpartum
Mothers and fathers self-reported parental reflective functioning measured with the Parental Reflective Functioning Questionnaire.
Six weeks postpartum
Parental reflective functioning
Time Frame: Four months postpartum
Mothers and fathers self-reported parental reflective functioning measured with the Parental Reflective Functioning Questionnaire.
Four months postpartum
Bonding between parent and child
Time Frame: Six weeks postpartum
Self-reported quality of bonding between parent and child measured with Maternal Postnatal Attachment Scale/Paternal Postnatal Attachment Scale.
Six weeks postpartum
Bonding between parent and child
Time Frame: Four months postpartum
Self-reported quality of bonding between parent and child measured with Maternal Postnatal Attachment Scale/Paternal Postnatal Attachment Scale.
Four months postpartum
Parent-child interaction
Time Frame: Four months postpartum
Parent-child interaction will be rated on the basis of 15-30 minutes videotaped episodes of parent-infant play interaction.
Four months postpartum
Parental stress
Time Frame: Six weeks postpartum
Self-reported measure of parental stress.
Six weeks postpartum
Parental stress
Time Frame: Four months postpartum
Self-reported measure of parental stress.
Four months postpartum
A composite measure of the infant´s temperament
Time Frame: Six months postpartum
Parents report of infant´s sensitivity, general activity, frustration tolerance, adaptability, regularity, and soothability.
Six months postpartum
Infants social withdrawal behaviour
Time Frame: Six months postpartum
Assessment of the infant's social withdrawal behaviour with The Alarm Distress Baby Scale.
Six months postpartum
Infant cognitive, communicative and motor development
Time Frame: Six months postpartum
Assessment of the infant's cognitive, communicative and motor development with The screening test version of Bayley Scales of Infant and Toddler Development
Six months postpartum
Heart rate variability
Time Frame: Six months postpartum
Mothers and infants heart rate variability will be measured with a wireless and unobtrusive electrocardiogram (ECG) equipment.
Six months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Catharina EA Wang, Professor, UiT The Arctic University of Norway

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

August 4, 2015

First Submitted That Met QC Criteria

August 31, 2015

First Posted (Estimate)

September 2, 2015

Study Record Updates

Last Update Posted (Actual)

May 17, 2019

Last Update Submitted That Met QC Criteria

May 15, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression, Postpartum

Clinical Trials on The Newborn Behavioral Observation (NBO)

3
Subscribe